OTC · Biotechnology

OKYO Pharma Limited (EMMLF) Stock

$0.01 +0.00% OTC: EMMLF Healthcare

OKYO Pharma Limited is an early-stage biopharmaceutical company focused on developing therapies for individuals experiencing inflammatory eye conditions and ocular pain. A key asset in their pipeline is OK-101, specifically aimed at treating dry eye disease.

Valuation

MetricValue
Price$0.01
Market Cap$22.73M
P/E Ratio-6.48
P/B Ratio4.70
P/S Ratio0.00
EPS (TTM)$0.00
52-Week High$0.89
52-Week Low$0.01
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-200.67%
ROA-42.67%
ROCE-74.59%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio2.43

Latest News

DTCC is helping Wall Street put real stocks onchain Yahoo Finance Video · Jul 16, 2026 Update: Technology Slide Pushes Nasdaq, S&P 500 Lower MT Newswires · Jul 16, 2026 Sector Update: Consumer Stocks Rise in Afternoon Trading MT Newswires · Jul 16, 2026 You Don’t Need Pershing Square to Own Bill Ackman’s Favorite Stocks. Here’s the Backdoor 24/7 Wall St. · Jul 16, 2026 The great bank migration: Banking loyalty must now be earned Retail Banker International · Jul 16, 2026

Valuation & Return Ratios

MetricValue
PEG Ratio0.05
EV / EBITDA-4.96
FCF Yield-9.86%
Quick Ratio2.43
Interest Coverage-20.81
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AMHVAmerican Hemp Ventures, Inc. $0.98 +0.00% — $16.47M 0.00%
IBXNFIBEX Technologies Inc. $1.00 -6.54% 9.06 $25.27M 0.00%
KMSTFKadimastem Ltd $3.21 -3.02% -1.52 $9.50M 0.00%
OCELOrganicell Regenerative Medicine, Inc. $2.74 -0.27% -4.73 $19.97M 0.00%
OPBXFOptiBiotix Health Plc $0.22 +0.00% -1.46 $20.06M 0.00%

About OKYO Pharma Limited

OKYO Pharma Limited is an early-stage biopharmaceutical company focused on developing therapies for individuals experiencing inflammatory eye conditions and ocular pain. A key asset in their pipeline is OK-101, specifically aimed at treating dry eye disease. Additionally, the company is advancing OK-201, which is a preclinical lipidated-peptide analogue sourced from bovine adrenal medulla, intended for the management of neuropathic ocular pain. Founded in 2007, OKYO Pharma Limited is headquartered in London, United Kingdom.

OKYO Pharma Limited is headquartered in GB.

OKYO Pharma Limited (EMMLF) stock trades at $0.01 with a market capitalization of $22.73M. The stock is valued at a price-to-earnings (P/E) ratio of -6.48, price-to-book of 4.70, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.01 and $0.89, and currently trades 98.9% below its 52-week high.

On profitability, OKYO Pharma Limited generates a return on equity (ROE) of -200.67%, return on capital employed of -74.59%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.okyopharma.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides